feed,title,long_url,short_url
InsiderMonkey,12 Best Stocks to Invest In for Good Returns,https://insidermonkey.com/blog/--1565875,
InsiderMonkey,Evercore ISI Upgrades SkyWest (SKYW) Stock to Outperform,https://insidermonkey.com/blog/--1566696,
InsiderMonkey,Wolfe Research Upgrades C.H. Robinson Worldwide (CHRW) Stock to Outperform,https://insidermonkey.com/blog/--1566698,
InsiderMonkey,Goldman Sachs Upgrades Oshkosh Corporation (OSK) Stock to Buy,https://insidermonkey.com/blog/--1566700,
InsiderMonkey,Roth Capital Begins Coverage of MasTec (MTZ) Stock With Buy rating,https://insidermonkey.com/blog/--1566702,
InsiderMonkey,"Wells Fargo Upgrades Cintas (CTAS) Stock to Equal Weight, Raises PT",https://insidermonkey.com/blog/--1566704,
InsiderMonkey,Baird Resumes Coverage of Union Pacific (UNP) Stock With a Neutral Rating,https://insidermonkey.com/blog/--1566706,
InsiderMonkey,UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR),https://insidermonkey.com/blog/--1566544,
InsiderMonkey,"Morgan Stanley Sees Rebound Potential in BioMarin (BMRN), Highlights Underappreciated Voxzogo Upside",https://insidermonkey.com/blog/--1566547,
InsiderMonkey,"HubSpot’s (HUBS) Growth Narrative Still Intact Despite Weak Q1, Jefferies Analyst Says",https://insidermonkey.com/blog/--1566551,
InsiderMonkey,Truist Sees Long Runway for QXO (QXO) Amid Housing and Infrastructure Tailwinds,https://insidermonkey.com/blog/--1566540,
InsiderMonkey,UBS Reiterates Buy on Deckers (DECK) as HOKA Momentum Powers Growth Outlook,https://insidermonkey.com/blog/--1566559,
InsiderMonkey,"Untapped Patient Base, Ingrezza Growth Keep Neurocrine (NBIX) on Guggenheim’s Buy List",https://insidermonkey.com/blog/--1566571,
InsiderMonkey,Stifel Stands by Okta (OKTA) with $130 Target as Identity Demand Grows,https://insidermonkey.com/blog/--1566579,
InsiderMonkey,"Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target",https://insidermonkey.com/blog/--1566594,
InsiderMonkey,MongoDB (MDB) Gets Vote of Confidence from William Blair Amid Market Skepticism,https://insidermonkey.com/blog/--1566605,
InsiderMonkey,Analyst Sees Strong Growth Pipeline for Workday (WDAY) Amid Healthy Enterprise Demand,https://insidermonkey.com/blog/--1566608,
InsiderMonkey,KeyBanc Analyst Stands by Salesforce (CRM) Despite Informatica Deal Concerns,https://insidermonkey.com/blog/--1566611,
